Evidence map›Paper›PMID 40275527›Full record

ArticleMicrobial biotechnology2025

Establishment of CRISPR-STAR System to Realise Simultaneous Transcriptional Activation and Repression in Yarrowia lipolytica.

Yaru Chen, Mengxu Li, Xuanwei Liu, Qiyang Duan, Lin Xiao, Luxin Wang, Congcong Huang, Hao Song, Yingxiu Cao

Abstract read
In one paragraph

Article in Microbial biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. 10 years of CRISPR/CAS genomic engineering in Yarrowia lipolytica.Bioprocess and biosystems engineering · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yaru ChenState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, China.
Mengxu LiState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, China.
Xuanwei LiuState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, China.
Qiyang DuanState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, China.
Lin XiaoState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, China.
Luxin WangState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, China.
Congcong HuangState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, China.
Hao SongState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, China.ORCID https://orcid.org/0000-0001-6481-4212
Yingxiu CaoState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, China.ORCID https://orcid.org/0000-0002-8762-8356

Funding

National Key Research and Development Program of China 2021YFC2104400the National Natural Science Foundation of China NSFC22078240the National Natural Science Foundation of China NSFC22478294
6 · The paper itself

Abstract

The ability to regulate gene expression in multiple directions is crucial to maximise the production of microbial cell factories. However, the lack of a regulatory tool that can simultaneously activate and repress multiple genes restricts the manipulation diversity of Yarrowia lipolytica, which is an industrial workhorse for bioproduction. To address this issue, we developed a CRISPR scaffold RNAs (scRNAs)-mediated transcriptional activation and repression (CRISPR-STAR) platform. Firstly, we evaluated different methods for bidirectional regulation using CRISPR on both endogenous and synthetic promoters in Y. lipolytica, and chose the utilisation of orthogonal scRNAs to recruit activation and inhibition domains. Secondly, CRISPR-STAR was optimised by the introduction of alternative dCas proteins, scRNA structures and activators. 2.6-fold and 54.9-fold activation were achieved for synthetic and endogenous promoters, respectively, when the VPR transcriptional activator was recruited via MS2 hairpin. The repression of several genes was successfully achieved, with repression levels ranging from 3% to 32%, when the MXI1 transcriptional repressor was recruited via PP7 hairpin. Finally, CRISPR-STAR was applied to enhance fatty alcohol production by activating the FAR gene (encodes fatty acyl-CoA reductase) and repression of the PEX10 gene (encodes an integral membrane protein required for peroxisome biogenesis and matrix protein import). Compared to the non-targeting control, the bidirectionally regulated strain showed a 55.7% increase in yield to 778.8 mg/L. Our findings demonstrate that the CRISPR-STAR platform enables multi-mode regulation of genes, offering engineering opportunities to improve the productive performance of Y. lipolytica.

Indexed as

CRISPR-Cas SystemsGene Expression Regulation, FungalTranscriptional ActivationYarrowiaClustered Regularly Interspaced Short Palindromic RepeatsPromoter Regions, GeneticCRISPR/dCas9 systemmultiplex genetic regulationscaffold RNAtranscriptional activationtranscriptional interferenceYarrowia lipolytica

Identifiers

PMID40275527
PMCPMC12021669

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.